Skip to content
Aperlena
Language:

Germany - Medicinal products - Open-House biosimilar discount contracts 2026-04 - Natalizumab i.v.

Original Deutschland - Arzneimittel - Open-House-Biologika-Rabattverträge 2026-04 - Natalizumab i.v.

Open Contract notice 583 days left
Watch this tender

Deadline 30 Apr. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 16 Apr, questions by 17 Apr, draft by 24 Apr. Log in

  1. Published
  2. Today
  3. Deadline open for 773 days
  4. Awarded pending

Summary

Machine-generated summary

German health insurance funds are seeking discount contracts under Section 130a paragraph 8 SGB V for the active substance natalizumab in a form for intravenous use. The procedure is an Open-House model: all suitable pharmaceutical entrepreneurs may join, individual negotiations do not take place and uniform conditions apply. No exclusivity is granted to any contract partner. Contracts run for a maximum of 24 months starting 01.05.2026 and end at the latest on 30.04.2028 regardless of the signing date. Joining is possible at any time during the contract term. Further details are in the participation and contract documents; the stated binding period is not relevant.

Description

Die beteiligten Kassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Natalizumab (Darreichungsform zur intravenösen Anwendung) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Biologika-Verfahrens der beteiligten Kassen: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die beteiligten Krankenkassen sichern einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.05.2026. Der Vertrag endet spätestens am 30.04.2028, unabhängig vom Datum des Vertragsschlusses. Ein Beitritt zu diesem Open-House-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Die gemachten Angaben zur Bindefrist sind vorliegend nicht relevant und ausschließlich den zwingenden Vorgaben des Formulars geschuldet Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen. Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Natalizumab (Darreichungsform zur intravenösen Anwendung) im Rahmen eines Open-House-Verfahrens.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

52 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now April 30, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,224,680
9,666 open across Europe right now
Buyer track record on Aperlena
55 notices tracked · 0 awarded

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

583 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close